Related Experiment Video
Updated: Jul 17, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae
Nicole Wolter1, Anthony M Smith, Donald E Low
1Respiratory and Meningeal Pathogens Research Unit, National Institute for Communicable Diseases, Medical Research Council and University of the Witwatersrand, Johannesburg, South Africa. nicolew@nicd.ac.za
Abstract:
A rare clinical isolate of Streptococcus pneumoniae, highly resistant to telithromycin, contained erm(B) with a truncated leader peptide and a mutant ribosomal protein L4. By transformation of susceptible strains, this study shows that high-level telithromycin resistance is conferred by erm(B), wild type or mutant, in combination with a (69)GTG(71)-to-TPS mutation in ribosomal protein L4.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Atypical Pneumonia
Development of Antibiotic Resistance
Inhibitors of Bacterial Protein Synthesis